Education

Education

Degree-Granting Education
Smith College, Northampton, MA, BS, 1979, Medicine
Washington University School of Medicine, St. Louis, MO, MD, 1983, Medicine

Postgraduate Training
Internship Internal Medicine, The University of Texas Health Science School of Medicine, Houston, TX, Thomas Andreoli, MD, 7/1983−6/1984
Residency Internal Medicine, The University of Texas Health Science Center School of Medicine, Houston, TX, Thomas Andreoli, MD, 7/1985−6/1986
Fellowship Pulmonary and Critical Care Medicine, Washington University School of Medicine Department of Respiratory and Critical Care Medicine, St. Louis, MO, Michael Holtzman, MD, 7/1988−6/1990

Biography

Dr. Vickie Shannon is a board certified Pulmonary and Critical Care Specialist. She is a full Professor in the Department of Pulmonary Medicine and Director of the Pulmonary Rehabilitation Program at MD Anderson Cancer Center.  Dr. Shannon received her medical degree and completed her fellowship training in Pulmonary and Critical Care Medicine at Washington University in St. Louis, Missouri. Board certified in Internal Medicine, Critical Care, and Pulmonary Medicine, she is also a member of the American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation, American Lung Association, and American College of Physicians, to name a few. Dr. Shannon is widely sought nationally and internationally as a guest lecturer.  Her research interests focus on pulmonary rehabilitation in the cancer setting, lung injury due to drug toxicity, lung infectionsin the immunocompromised host,muscle physiology, respiratory physiology, and exercise physiology.

Research Interest

Research interests focus on pulmonary rehabilitation in the cancer setting, lung injury due to drug toxicity, lung infectionsin the immunocompromised host,muscle physiology, respiratory physiology, and exercise physiology.

Scientific Activities

Credentials
Board Certification

• American Board of Internal Medicine - Internal Medicine, 9/1991−10/2022, Recertification Date:10/2012
• American Board of Internal Medicine - Pulmonary Medicine, 1992
• American Board of Internal Medicine - Critical Care, 1992

Licensures

• Texas State Board of Medical Examiners License, TX, G7762, 5/1988−5/2099
• Missouri State Board Medical Examiners License, MO, R6H04, 5/1988−5/2008

Experience / Service
Academic Appointments

• Instructor, Division of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 1/1990−1/1993
• Attending Physician, Medical Service, Veteran Administration Medical Center, St. Louis, MO, 1/1991−1/1993
• Attending Physician, Division of Internal Medicine, Washington University School of Medicine Barnes Hospital, St. Louis, MO, 1/1991−1/1993
• Attending Physician, Department of Internal Medicine, Division of Internal Medicine, Washington University School of Medicine Jewish Hospital, St. Louis, MO, 1/1991−1/1993
• Assistant Professor, Department of Pulmonary Medicine, Division of Internal Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX, 3/1993−9/1998
• Associate Professor, Department of Pulmonary Medicine, Division of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 9/1998−8/2006
• Associate Professor, Department of Critical Care, Division of Critical Care Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 9/1998−8/2006
• Professor, Department of Pulmonary Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2006−present

Administrative Appointments/Responsibilities

• Women Faculty & Administrators Organization, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/1995
• Administrative Director, Section of Pulmonary Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/1998−1/2001
• Co-Director - Medical Specialties Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/1998−1/2001
• Director of the Pulmonary Fellowship Program, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/1998−1/2001

Other Appointments/Responsibilities

• Mentor, King Foundation, Houston, TX, 1999−present
• Director of Pulmonary Rehabilitation, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005−present
• Member, ACCP Women's Health Network Steering Committee, Chicago, IL, 2007−present
• Member, The Chest Foundation, Chicago, IL, 2007−present
• Panelist appointment, Texas Medical Board, Houston, TX, 2009−present

Institutional Committee Activities

• Minority Faculty Committee, Member, 1/1993−8/2004
• Medical Records Subcommittee, Member, 1/1997−8/2002
• Antibiotic Task Force, Member, 1998−present
• Clinical Ethics Committee, 1/1998−1/2001
• Sedation Credentialing Committee, Member, 1999−2005
• Sedation and Procedures Committee, Co-Chairperson, 1/1999−8/2002
• Intensive Care Unit Planning Committee, Member, 1/1999−8/2007
• Faculty Senate, Member, 2001−present
• Credentials Committee for Medical Staff, Member, 2001−present
• Clinical Credentialing Medical Staff Committee, Member, 9/2003−present
• Multi-Year Award Committee, Member, 2004−present
• Ethnics Committee, Member, 9/2007−8/2008
• CFRC Committee, Member, 2008−2012
• IRB Committee, Member, 2008−present
• PRS Budget & Finance Committee, Member, 2010−present
• PRS Leadership & Institutional Service Award Committee, Member, 10/2012−present
• Medical Student Summer Program Committee, Chair, 2/2013−present
• Clinical Faculty Review Committee, Vice Chair, 9/2013−present

Honors And Awards

• Smith College Scholastic Achievement Award, Smith College, 1978
• History of Medicine Award, University of Texas, 1985
• NIH (Heart, Lung, and Blood Institute) Minority Investigator Award, NIH, 1990
• Alfred Soffer Research Award, American College of Chest Physicians CHEST Foundation, 2011

Publications

Peer-Reviewed Original Research Articles

• Shannon VR, Crouch EC, Takahashi Y, Ueda N, Yamamoto S, Holtzman MJ. Related expression of arachidonate 12- and 15-lipoxygenases in animal and human lung tissue. Am J Physiol 261(6 Pt 1):L399-405, 12/1991.
• Shannon VR, Hansbrough JR, Takahashi Y, Ueda N, Yamamoto S, Holtzman MJ. Biochemical and immunohistochemical evidence for selective expression of novel epithelial lipoxygenases. Adv Prostaglandin Thromboxane Leukot Res 21A:37-40, 1991.
• Shannon VR, Stenson WF, Holtzman MJ. Induction of arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. Am J Physoil (Gastorinterol) 264:G104-111, 1991.
• Shannon VR, Ramanadham S, Turk J, Holtzman MJ. Selective expression of an arachidonate 12-lipoxygenase by pancreatic islet beta-cells. Am J Physiol 263(5 Pt 1):E828-36, 11/1992.
• Shannon VR, Chanez P, Bousquet J, Holtzman MJ. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis 147(4):1024-8, 4/1993.
• Shannon VR, Stenson WF, Holtzman MJ. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. Am J Physiol 264(1 Pt 1):G104-11, 1993.
• Hussain H, Shornick LP, Shannon VR, Wilson JD, Funk CD, Pentland AP, Holtzman MJ. Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis. Am J Physiol 266(1 Pt 1):C243-53, 1994.
• Shannon VR, Nesbitt JC, Libshitz HI. Malignant pleural mesothelioma after radiation therapy for breast cancer. A report for two additional patients. Cancer 76(3):437-41, 8/1995.
• Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 158(3):876-84, 9/1998.
• Gruber M, Molke KL, Siegel E, DeJesus Y, Roquemore J, Shannon V, Porche VH, Luther KM. Development of an outcome variance tracking tool for sedation and non surgical procedures. Gastroenterol Nurs 24(6):276-80, Nov-Dec, 11/2001.
• Wong R, Rondon G, Saliba RM, Shannon VR, Giralt SA, Champlin RE, Ueno NT. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high risk breast cancer. Bone Marrow Transplant 31(12):1157-63, 6/2003.
• Estabrooks PA, Munroe KJ, Fox EH, Gyurcsik NC, Hill JL, Lyon R, Rosenkranz S, Shannon VR. Leadership in physical activity groups for older adults: a qualitative analysis. J Aging Phys Act 12(3):232-45, 7/2004.
• Bristol I, Brown J, Slomovitz BM, Shannon VR, Eifel PJ. Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report. Gynecol Oncol 97(3):953-6, 6/2005.
• Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Keus L, Lin E, Morice RC. Pulmonary dysfunction as a major cause of inoperability among patients with non-small-cell lung cancer. Clin Lung Cancer 7(5):344-9, 3/2006.
• Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 130(6):1784-90, 12/2006.
• Gupta S, Jain A, Warneke CL, Gupta A, Shannon VR, Morice RC, Onn A, Jimenez CA, Bashoura L, Giralt SA, Dickey BF, Eapen GA. Outcome of alveolar hemorrhage in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 40(1):71-8, 7/2007. e-Pub 5/2007.
• Morris GS, Gallagher GH, Baxter MF, Brueilly KE, Scheetz JS, Ahmed MM, Shannon VR. Pulmonary rehabilitation improves functional status in oncology patients. Arch Phys Med Rehabil 90(5):837-41, 5/2009.
• Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 45(4):647-55, 4/2010. e-Pub 8/2009.
• Shannon VR. Role of pulmonary rehabilitation in the management of patients with lung cancer. Curr Opin Pulm Med 16(4):334-9, 7/2010.
• Clement D, Shannon VR. Injured athletes' perceptions about social support. J Sport Rehabil 20(4):457-70, 11/2011.
• Milbury K, Chaoul A, Engle R, Liao Z, Yang C, Carmack C, Shannon V, Spelman A; Wangyal T; Cohen L. Couple-based Tibetan yoga program for lung cancer patients and their caregivers. Psycho-Oncology. In Press.

Abstracts (past 5 years)

• Morris GS, Baxter MF, Gallagher G, Ahmed M, Scheetz JS, Shannon VS. Pulmonary Rehabilitation in an Oncology Setting. A Preliminary Report. AJCVPR, 2009.
• Shannon VR, Thurman C, Maldonado J. Timing of PR Relative to Lung Cancer Treatment Impacts PR Benefits. ACCP International Meeting, 2011.
• Shannon V. Pulmonary Rehabilitation improves exercise tolerance and quality of life among allogeneic hematopoietic stem cell transplant recipients with late-onset noninfectious pulmonary complications (LONIPCs). ACCP International Meeting, 2012.

Book Chapters

• Shannon VR, Hansbrough JR, Takahashi Y, Ueda N, Yamamoto S, Holtzman MJ. Biochemical and immunohstochemical evidence for selective expression of novel epithelial lipoxygenase. In: Raven Press, p37-40, 1990.
• Holtzman MJ, Shannon VR, Masi AM, Look D C. Mechanisms of airway inflammation and implications for future treatment of asthma and bronchitis. In: Drugs and the Lung. Raven Press, 549-583, 1994.
• Shannon VR, Price KJ. Pulmonary Complications of Cancer Therapy. In: Anesthesiology Clinics of North America. 16(3). W. B. Saunders Company, 563–586, 1998.
• Shannon VR, Dickey BF. Critical Care of the Cancer Patient with Pulmonary Infiltrates. In: Perioperative Cancer Medicine: Anesthesia, Critical Care and Pain Control. Marcel Decker, Inc, 2000.
• Shannon VR, Ng AW. Emergent Pulmonary Infections. In: Oncologic Emergencies. BCD Decker Company, 249, 2000.
• Shannon VR. Heart-Lung Interactions in the Cancer Patient. In: Cancer and the Heart. BC Decker, Inc., 2000.
• Shannon VR, Ng AW. Noninfectious Pulmonary Emergencies. In: Noninfectious Pulmonary Emergencies. BCD Decker Company, 191, 2000.
• Shannon VR, Eapen G. Pulmonary Complications Among Immunocompromised Hosts following Hematopoietic Stem Cell Transplantation. In: Respiratory Emergencies. Hodder-Arnold Publishing Co., 2000.
• Shannon VR, Eapen G, Carlos J, Morice R, Travis E, et al. Respiratory Complications. In: Cancer Medicine. BC Decker, 2000.
• Gao S, Shannon VR. Vascular Emergencies. In: Oncologic Emergencies. BCD Decker Company, 315, 2000.
• Shuwei G, Shannon VR. In Pulmonary Oncologic Emergencies. In: BC Decker Inc, p315-388, 2001.
• Shannon VR. Noninfectious pulmonary oncological emergencies. In: In Pulmonary Oncologic Emergencies. BC Decker, 249-269, 2001.
• Shannon VR, NG Aw. Pulmonary infectious oncologic emergencies. In: In Pulmonary Oncologic Emergencies. B Decker, 191-248, 2001.
• Shannon VR. Superior vena cava syndrome. In: In Pulmonary Oncologic Emergencies. BC Decker, 315-388, 2001.
• Shannon VR. Critical Care of the cancer patient with pulmonary infiltrates. In: Acute care of the Cancer Patient. Ed(s) Shannon VR, Dickey BF. Taylor & Francis Group, 579-668, 2006.
• Shannon VR. Heart-Lung interactions in the cancer patient. In: Cancer and the Heart. BC Decker, 289-328, 2006.
• Shannon VR, Eapen GA, Jimenez CA, Morice RC, Travis EL, Bashoura L, Safdar A, Evans SE, Adachi R, Faiz S, Balachandran DD, Nates JL, Pravinkumar SE, Dickey BF. Respiratory Complications. In: Holland-Frei Cancer 8 Medicine, AACR. BC Decker, 2010.
• Shannon VR, Faiz S. Heart-lung Interactions in the Cancer Patient. In: Cancer and the Heart, 2nd. Ed(s) Ewer & Yeh. People's Medical Publishing House-USA: Shelton, CT, 386-442, 2013.
• Shannon VR. Pulmonary Rehabilitation. In: Rehabilitation Medicine Quick Reference. Ed(s) KY Shin, MD. Demos Medical PUblishing: New York, 14-16, 2014.